Anti-cancer Potential of Captopril and Botulinum Toxin Type-A and Associated p53 Gene Apototic Stimulating Activity

Mutational inactivation of p53 is a key player in the development of human cancer. Thus, retrieving the tumor suppressor activity of p53 gene is considered a novel strategy in cancer therapy. Current study aimed to investigate the anti-cancer potentials of botulinum toxin type-A (BTX-A) and captopri...

Descripción completa

Detalles Bibliográficos
Autor principal: Shebl, Rania Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059072/
https://www.ncbi.nlm.nih.gov/pubmed/32184862
http://dx.doi.org/10.22037/ijpr.2019.1100800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059072/
https://www.ncbi.nlm.nih.gov/pubmed/32184862
http://dx.doi.org/10.22037/ijpr.2019.1100800

Ejemplares similares